MedPath

Analysis of 1-methyladenosine for a biomarker in patients with diffuse large B-cell lymphoma.

Not Applicable
Completed
Conditions
diffuse large B-cell lymphoma
Registration Number
JPRN-UMIN000020756
Lead Sponsor
Kanazawa Medical University
Brief Summary

nder analysis

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
16
Inclusion Criteria

Not provided

Exclusion Criteria

DLBCL cases who are treated by other chemotherapy regimen.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath